Unremarkable antibody responses against various infectious agents after inoculation with the BNT162b2 COVID-19 vaccine

J Med Virol. 2022 Oct;94(10):4583-4585. doi: 10.1002/jmv.27895. Epub 2022 Jun 9.

Authors

Kei Kozawa¹, Hiroki Miura¹, Yoshiki Kawamura¹, Yuki Higashimoto², Masaru Ihira³, Tetsushi Yoshikawa¹

Affiliations

¹ Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
² Faculty of Clinical Science for Cellular and Molecular Biology, Fujita Health University School of Health Sciences, Toyoake, Aichi, Japan.
³ Faculty of Clinical Science for Biological Monitoring, Fujita Health University School of Health Sciences, Toyoake, Aichi, Japan.

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Viral
Antibody Formation*
BNT162 Vaccine
COVID-19 Vaccines
COVID-19* / prevention & control
Humans
Vaccination

Substances

Antibodies, Viral
COVID-19 Vaccines
BNT162 Vaccine